首页> 外文期刊>International journal of immunopathology and pharmacology. >Influence on Chondrogenesis of Human Osteoarthritic Chondrocytes in Co-Culture with Donor-Matched Mesenchymal Stem Cells from Infrapatellar Fat Pad and Subcutaneous Adipose Tissue
【24h】

Influence on Chondrogenesis of Human Osteoarthritic Chondrocytes in Co-Culture with Donor-Matched Mesenchymal Stem Cells from Infrapatellar Fat Pad and Subcutaneous Adipose Tissue

机译:Don骨脂肪垫和皮下脂肪组织与供体匹配的间充质干细胞共培养对人骨关节炎软骨细胞软骨形成的影响

获取原文
       

摘要

Co-culture of mesenchymal stem cells (MSCs) and articular chondrocytes (ACs) has been proposed for autologous cartilage cell-based therapies, to overcome the issues associated to limited availability of articular chondrocytes (ACs). To evaluate the potentiality of a co-culture approach in aged osteoarthritic patients, MSCs from infrapatellar fat pad (IFP-MSCs) and knee subcutaneous adipose tissue (ASCs) were co-cultured with donor-matched osteoarthritic, expanded and cryopreserved, ACs in a 75%/25% ratio. Co-cultures were prepared also from nasal chondrocytes (NCs) to evaluate their possible use as an alternative to ACs. Pellets were differentiated for 14 days, using mono-cultures of each cell type as reference. Chondrogenic genes SOX9, COL2A1, ACAN were less expressed in co-cultures compared to ACs and NCs. Total GAGs content in co-cultures did not differ significantly from values predicted as the sum of each cell type contribution corrected for the co-culture ratio, as confirmed by histology. No significant differences were observed for GAGs/DNA in mono-cultures, demonstrating a reduced chondrogenic potential of ACs and NCs. In conclusion, a small percentage of expanded and cryopreserved ACs and NCs did not lead to IFP-MSCs and ASCs chondro-induction. Our results suggest that chondrogenic potential and origin of chondrocytes may play a relevant role in the outcome of co-cultures, indicating a need for further investigations to demonstrate their clinical relevance in the treatment of aged osteoarthritic patients.
机译:已经提出将间充质干细胞(MSC)和关节软骨细胞(AC)共培养用于基于自体软骨细胞的疗法,以克服与关节软骨细胞(AC)的有限可用性相关的问题。为了评估老年骨关节炎患者共培养方法的潜力,将donor下脂肪垫(IFP-MSC)和膝下皮下脂肪组织(ASC)的骨髓间充质干细胞与供体匹配的骨关节炎,扩张和冷冻保存的AC共同培养。 75%/ 25%的比例。还从鼻软骨细胞(NC)制备共培养物,以评估其可能替代AC的用途。使用每种细胞类型的单一培养物作为参照,将药丸分化14天。与AC和NC相比,软骨培养基因SOX9,COL2A1,ACAN在共培养物中表达较少。共培养中的总GAG含量与预测的值没有显着差异,因为组织学证实,每种值均针对共培养比率进行了校正,校正后的每种细胞类型的总和。在单一培养物中未观察到GAG / DNA的显着差异,这表明AC和NC的软骨形成潜力降低。总之,一小部分扩大和冷冻保存的AC和NC不会导致IFP-MSC和ASC的软骨诱导。我们的结果表明,软骨细胞的软骨形成潜力和起源可能在共培养的结果中起着重要作用,这表明需要进一步研究以证明其在治疗老年骨关节炎患者中的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号